276471 people have viewed this drug in the last 60 days
Updated 2025-10-03
Last Update | 2022-11-30 |
Register Year | 2020 |
Product Type | Human |
Drug Type | Biological |
Scientific Name | RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN THE NHBA,RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN THE NHBA I,RECOMBINANT N MENINGITIDIS SEROGROUP B NADA PROTEIN,RECOMBINANT N MENINGITIDIS SEROGROUP B NADA PROTEIN I,RECOMBINANT N MENINGITIDIS SEROGROUP B FHBP FUSION PROTEIN,RECOMBINANT N MENINGITIDIS SEROGROUP B FHBP FUSION PROTEIN I,OUTER MEMBRANE VESICLES FROM N MENINGITIDIS SEROGROUP B STRAIN NZ98254 |
Trade Name | Bexsero |
Strength Unit | µg |
Pharmaceutical Form | Suspension for injection in pre-filled syringe |
Administration Route | Intramuscular use |
Atc Code1 | J07AH09 |
Atc Code2 | |
Size | 0.5 |
Size Unit | ml |
Package Types | Pre-filled syringe |
Package Size | 1 |
Legal Status | Prescription |
Product Control | Uncontrolled |
Distribute Area | Hospital |
Public price | $347.9 |
Shelf Life | 36 Months |
Marketing Company | Glaxo Saudi Arabia Ltd |
Marketing Country | Saudi Arabia |
Manufacture Name | GSK Vaccines Srl |
Manufacture Country | Italy |
Secondry package manufacture | |
Main Agent | SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO) |
Secosnd Agent | |
Third Agent | |
Visits | 276471 |
Do not forget, after purchasing the medicine, help us determine the price more accurately, press the button below and adjust the price directly
Name | Price | Visits | Updated |
---|---|---|---|
Bexsero | $347.9 | 276471 visits | 2022-11-30 |